Acalabrutinib

Acalabrutinib


Acalabrutinib (ACP-196) is an orally active, irreversible, and highly selective second-generation BTK inhibitor that covalently binds Cys481 in BTK’s ATP-binding pocket. It demonstrates potent efficacy in CLL models and features an alkyne group for CuAAC click chemistry reactions. Reagent grade, for research use only.

Molecular structure of the compound BP-43623
    • Unit
    • Price
    • Qty
    • 250 MG
    • $140.00
    • 500 MG
    • $235.00
    • 1 G
    • $399.00

Usually ships within 24 hours.


Would you like to inquire about custom quantity?
Inquire